These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9352330

  • 1. Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphocytic leukemia.
    Bay JO, Fouassier M, Béal D, Alcaraz L, Cure H, Chollet P, Plagne R, Travade P.
    Hematol Cell Ther; 1997 Aug; 39(4):209-12. PubMed ID: 9352330
    [Abstract] [Full Text] [Related]

  • 2. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
    Tertian G, Cartron J, Bayle C, Rudent A, Lambert T, Tchernia G.
    Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
    Rossi JF, van Hoof A, de Boeck K, Johnson SA, Bron D, Foussard C, Lister TA, Berthou C, Kramer MH, Littlewood TJ, Marcus RE, Deconinck E, Montillo M, Guibon O, Tollerfield SM.
    J Clin Oncol; 2004 Apr 01; 22(7):1260-7. PubMed ID: 15051774
    [Abstract] [Full Text] [Related]

  • 4. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
    Miyawaki S, Imamura M, Kobayashi S, Ohnishi K, Hodohara K, Mizoguchi H, Tomonaga M, Tango T, Ohno R.
    Rinsho Ketsueki; 1999 Dec 01; 40(12):1236-44. PubMed ID: 10658476
    [Abstract] [Full Text] [Related]

  • 5. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.
    Puccio CA, Mittelman A, Lichtman SM, Silver RT, Budman DR, Ahmed T, Feldman EJ, Coleman M, Arnold PM, Arlin ZA.
    J Clin Oncol; 1991 Sep 01; 9(9):1562-9. PubMed ID: 1714949
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H, Murase T, Ueno H, Park JW, Yano T, Ikeda Y.
    Leuk Res; 2006 Dec 01; 30(12):1589-90. PubMed ID: 16542723
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
    Cortes J, O'Brien S, Loscertales J, Kantarjian H, Giles F, Thomas D, Koller C, Keating M.
    Cancer; 2001 Oct 15; 92(8):2016-22. PubMed ID: 11596014
    [Abstract] [Full Text] [Related]

  • 9. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
    Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie KB.
    Blood; 1989 Jul 15; 74(1):19-25. PubMed ID: 2473795
    [Abstract] [Full Text] [Related]

  • 10. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR, Kopecky KJ, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley R, Von Hoff DD, Balcerzak SP.
    Nouv Rev Fr Hematol (1978); 1988 Jul 15; 30(5-6):457-9. PubMed ID: 2464793
    [Abstract] [Full Text] [Related]

  • 11. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine.
    Di Raimondo F, Giustolisi R, Cacciola E, O'Brien S, Kantarjian H, Robertson LB, Keating MJ.
    Leuk Lymphoma; 1993 Sep 15; 11(1-2):63-8. PubMed ID: 8220155
    [Abstract] [Full Text] [Related]

  • 12. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.
    Boogaerts MA, Van Hoof A, Catovsky D, Kovacs M, Montillo M, Zinzani PL, Binet JL, Feremans W, Marcus R, Bosch F, Verhoef G, Klein M.
    J Clin Oncol; 2001 Nov 15; 19(22):4252-8. PubMed ID: 11709569
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia.
    Montillo M, Tedeschi A, Leoni P.
    Leuk Lymphoma; 1994 Sep 15; 15(1-2):187-8. PubMed ID: 7858499
    [No Abstract] [Full Text] [Related]

  • 15. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
    Keating MJ, Kantarjian H, O'Brien S, Koller C, Talpaz M, Schachner J, Childs CC, Freireich EJ, McCredie KB.
    J Clin Oncol; 1991 Jan 15; 9(1):44-9. PubMed ID: 1702145
    [Abstract] [Full Text] [Related]

  • 16. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
    Wells T, Kovacs MJ.
    Ann Pharmacother; 2003 May 15; 37(5):671-4. PubMed ID: 12708944
    [Abstract] [Full Text] [Related]

  • 17. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
    Leach M, Parsons RM, Reilly JT, Winfield DA.
    Clin Lab Haematol; 2000 Jun 15; 22(3):175-8. PubMed ID: 10931169
    [Abstract] [Full Text] [Related]

  • 18. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Kyasa MJ, Parrish RS, Schichman SA, Zent CS.
    Am J Hematol; 2003 Sep 15; 74(1):1-8. PubMed ID: 12949883
    [Abstract] [Full Text] [Related]

  • 19. Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia.
    MacCallum S, Groves M, Brass D, Cunningham J, Sales M, Gelly K, Tauro S.
    J Clin Pathol; 2009 May 15; 62(5):468-70. PubMed ID: 19398596
    [Abstract] [Full Text] [Related]

  • 20. Fludarabine monophosphate in refractory B-chronic lymphocytic leukemia: maintenance may be significant to sustain response.
    Angelopoulou MA, Poziopoulos C, Boussiotis VA, Kontopidou F, Pangalis GA.
    Leuk Lymphoma; 1996 Apr 15; 21(3-4):321-4. PubMed ID: 8726414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.